Is the price fair?
What LKFT's price assumes
Lakefront Biotherapeutics NV has no trailing P/E on file, so the price is measured against sales instead: 1.89× revenue.
1.89
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.61
Price / book · as of 2026-Q1
- EV / sales
- 1.83
EV / sales
Details›
- Price / book2026-Q1
- 0.61
- EV / EBIT2026-Q1
- 3.21
- EV / sales2026-Q1
- 1.83
- Market capitalisation
- $1.90B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.